FONAR TO INTRODUCE WORLD'S FIRST
A MAJOR ADVANCE FOR SPORTS MEDICINE,
TRAUMA CENTERS AND CARDIOVASCULAR DIAGNOSIS
NEW YORK, November 23, 1999 -- FONAR Corporation (NASDAQ-FONR),
The Open MRI Company, announced plans to introduce The
Stand-Up MRI, which will provide for the first time MRI
images of the patient in the weight-bearing state. This technology
is a superior diagnostic tool for spines and joints and is the
first of its kind in the MRI industry. "It will be especially
valuable for a host of different applications in sports medicine,"
said Dr. Raymond Damadian, president and founder of FONAR.
unique design of The Stand-Up MRI enables full range-of-motion
movements of any joint in virtually any direction, especially
important in the diagnosis of sports injuries, but an impossibility
in any other MRI scanner on the market. Cardiovascular MRI evaluations
can also be performed when the patient is standing or when the
patient's feet are elevated above his or her head in the Trendelenburg
from The Stand-Up MRI will be shown for the first time
on this works-in-progress scanner, at the Radiological Society
of North America (RSNA). The RSNA meeting is the world's largest
medical trade show and starts on November 28 in Chicago.
50 percent of MRI scans are conducted on the spine," said Dr.
Damadian. "This is a truly a remarkable diagnostic tool and
the need for this one-of-a-kind product is great."
Stand-Up MRI will be ideal for trauma centers where cardiovascular
evaluations are key and where immediate and easy-access MRI
screening can improve a patient's chances for survival," said
1980, FONAR introduced the world's first commercial MRI whole-body
scanner. The widespread application of Magnetic Resonance Imaging
(MRI) in medicine and biology today is the direct result of
the landmark discoveries and early pioneering work of Dr. Damadian.
His seminal discoveries of the variations in soft body tissue
relaxation times, as well as the cancer detecting NMR signal,
are the means used by all MRI scanners to detect cancer and
distinguish healthy versus diseased tissues. A 1997 U.S. Supreme
Court ruling affirmed that Dr. Damadian's patented discoveries
are fundamental to every MRI unit in the marketplace today.